PepperLime Health Acquisition Corporation
PEPL
NASDAQ Global Market10.93
USD
+0.02
- -
CIK
0001873324
ISIN
KYG700211033
CUSIP
G70021103
Return %
Stock
S&P500
1Y
6.53
26.53
3Y
11.19
76.60
5Y
11.19
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Ramzi Haidamus
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 548 Market Street San Francisco CA United States of America 94104
- IPO Date
- Dec 9, 2021
- CIK
- 0001873324
- Website
- pepperlimehealth.com
- Similar Companies
- Business
- PepperLime Health Acquisition Corporation (NASDAQ: PEPL), a blank check company formed in 2021 and headquartered in San Francisco, California, focuses on effecting mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses at the intersection of technology and consumer health and wellness. The company has no current operating products or services, as its core activities center on identifying and completing an initial business combination in the consumer health, wellness, digital health, and technology-enabled sectors; it targets opportunities in areas such as measurement- and personalized-based care, connected communities, e-commerce, and subscription models. In recent developments, shareholders unanimously approved a six-month extension of the merger deadline to April 19, 2024, in August 2023, supported by sponsor deposits into trust; however, the company announced in January 2024 its inability to consummate a business combination by the deadline, leading to a prompt liquidation process, with pro rata distributions to record holders from the trust account completed by March 2024 and Nasdaq delisting shortly thereafter. Incorporated in the Cayman Islands and operating principally in the United States, PepperLime Health raised $150 million in its October 2021 initial public offering, with no subsidiaries or parent relationships noted.